[Experiences with dimenhydrinate (Vomex A retard) in cytostatic incompatibility].
D000970:Antineoplastic Agents / Q000009:adverse effects*; D003692:Delayed-Action Preparations; D004111:Dimenhydrinate / Q000627:therapeutic use*; D004344:Drug Incompatibility; D006801:Humans; D009325:Nausea / Q000188:drug therapy; D009369:Neoplasms / Q000188:drug therapy; D014839:Vomiting / Q000188:drug therapy
D000970:Antineoplastic Agents; D003692:Delayed-Action Preparations; D004111:Dimenhydrinate
Erfahrungen mit Dimenhydrinat (Vomex A retard) bei Zytostatikaunverträglichkeit.